Genetic Technology--Innovations in Clinical Proteomics

USD 250.00

* Required Fields

USD 250.00


Be the first to review this product

This edition of Genetic Technology TechVision Opportunity Engine (TOE) depicts the current landscape and the new life sciences trends across innovations in clinical proteomics. The corresponding patent scenario related to clinical proteomics is depicted along with industry interactions.The Genetic Technology TOE presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and geneti

Table of Contents

Genetic Technology--Innovations in Clinical ProteomicsTechnology ProfilesTargeted Proteomics for Biomarker DiscoveriesA Novel Alternative for Antibodies and AptamersSecond generation Assays for Poly(ADP-ribose) polymerasesCompanion Diagnostic for Retinal HealthAppendixPatent ScenarioPatent ScenarioIndustry Interactions

Related Research

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.